Key result
CaNVAS ultrasound measures vascular parameters with ~95% accuracy compared to a sphygmomanometer.
Why the study?
Traditional vascular parameter assessments rely on cuff-based or invasive methods with manual calculations, creating a need for automated, continuous, and non-invasive in vivo measurement tools.
Does the CaNVAS device accurately measure vascular parameters compared to standard sphygmomanometry in human subjects?
Observational (n=250)
Does the CaNVAS device accurately measure vascular parameters compared to standard sphygmomanometry in human subjects?
Effect estimate: CV 12.5%
A novel ultrasound-based device (CaNVAS) can continuously and non-invasively measure vascular parameters with 95% accuracy.
This paper presents the feasibility of automated and accurate in vivo measurements of vascular parameters using an ultrasound sensor. The continuous and non-invasive monitoring of certain parameters, such as pulse wave velocity (PWV), blood pressure (BP), arterial compliance (AC), and stiffness index (SI), is crucial for assessing cardiovascular disorders during surgeries and follow-up procedures. Traditional methods, including cuff-based or invasive catheter techniques, serve as the gold standard for measuring BP, which is then manually used to calculate AC and SI through imaging algorithms. In this context, the Continuous and Non-Invasive Vascular Stiffness and Arterial Compliance Screener (CaNVAS) is developed to provide continuous and non-invasive measurements of these parameters using an ultrasound sensor. By driving 5 MHz (ranging from 2.2 to 10 MHz) acoustic waves through the arterial walls, capturing the reflected echoes, and employing pre-processing techniques, the frequency shift is utilized to calculate PWV. It is observed that PWV measured by CaNVAS correlates exponentially with BP values obtained from the sphygmomanometer (BPMR-120), enabling the computation of instantaneous BP values. The proposed device is validated through measurements conducted on 250 subjects under pre- and post-exercise conditions, demonstrating an accuracy of 95% and an average coefficient of variation of 12.5%. This validates the reliability and precision of CaNVAS in assessing vascular parameters.
No takes yet. Share an insight, caveat, or question.
Sikkandar et al. (2023) reported an observational. Continuous and Non-Invasive Vascular Stiffness and Arterial Compliance Screener (CaNVAS) vs. Sphygmomanometer (BPMR-120) was evaluated on Accuracy and coefficient of variation of vascular parameter measurements (CV 12.5%). The CaNVAS ultrasound device measured vascular parameters with 95% accuracy and an average coefficient of variation of 12.5% compared to a sphygmomanometer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: